Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Equibles does not estimate personal net worth.
Russell Skibsted was last confirmed as CFO at Rockwell Medical, Inc. (RMTI) in a filing dated April 8, 2022. The proxy statement of Rockwell Medical, Inc. reports total compensation of $598,923 for Russell Skibsted in fiscal 2021, including a base salary of $460,000. Disclosed compensation is on record for 2 fiscal years. Russell Skibsted has spoken on 7 earnings calls across 1 company, most recently for Rockwell Medical, Inc. on August 15, 2022. The companies whose calls Russell Skibsted spoke on are classified in the Healthcare sector.
“During the second quarter of 2022, Rockwell raised a total of $30 million, which included $15 million from our long-time partner, DaVita. As a result, our cash and cash equivalents as of June 30, 2022, was approximately $30.8 million.”
“We ended the first quarter of 2022 with cash and cash equivalents of approximately $9.9 million. Of course, this figure does not include the $7.5 million investment from DaVita, which closed in April.”
“We ended the third quarter of 2021, with cash, cash equivalents, and investments of approximately $33.2 million, which was in line with our expectations and which we believe keeps us in a position to drive our company's strategic initiatives.”
“We ended the second quarter with cash, cash equivalents and investments of approximately $41 million. We believe we remain in a strong financial position to drive our company's strategic initiatives.”
“Our dialysis business, which is comprised of revenue from both Triferic and concentrates, continued to steadily perform.”
Start not stated–2022-04-08
Last confirmed by a filing; no departure on record
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Rockwell Medical, Inc. (RMTI) | Former Chief Financial Officer^(b)^ | $460,000 | $598,923 |
| 2020 | Rockwell Medical, Inc. (RMTI) | Chief Financial Officer | $130,923 | $717,142 |